Needham Maintains Buy on Cogent Biosciences, Lowers Price Target to $23
Needham analyst Ami Fadia maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and lowers the price target from $24 to $23.
SVB Leerink Maintains Outperform on Cogent Biosciences, Raises Price Target to $20
SVB Leerink analyst Andrew Berens maintains Cogent Biosciences (NASDAQ:COGT) with a Outperform and raises the price target from $18 to $20.
Guggenheim Maintains Buy on Cogent Biosciences, Raises Price Target to $24
Guggenheim analyst Charles Zhu maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $22 to $24.
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Cogent Biosciences Touts Positive Data From Bezuclastinib Study In Mastocytosis Patients
Cogent Biosciences Inc (NASDAQ:COGT) announced positive updated clinical data from its ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with…
Cogent Biosciences Announced Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosisl; Announced 89% ORR in TKI-therapy Naïve Patients; 73% ORR in All Evaluable Patients with 27-wee…
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced positive updated clinical data from its ongoing Phase 2 APEX clinical trial evaluating the selective KIT D816V inhibitor bezuclastinib in patients with advanced systemic m
SVB Leerink Maintains Outperform on Cogent Biosciences, Lowers Price Target to $18
SVB Leerink analyst Andrew Berens maintains Cogent Biosciences (NASDAQ:COGT) with a Outperform and lowers the price target from $20 to $18.
Denbury, Global-e Online And Agilent Among Top Gainers On Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping around 170 points. Here is the list of some big stocks moving higher in the previous session.
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.
89 Biggest Movers From Friday
Gainers
Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.